HOME >> BIOLOGY >> NEWS
Cumbre Inc. and collaborator publish on a novel bacterial RNA polymerase inhibitor

Dallas, Oct. 23/ Cumbre Inc., a privately held biopharmaceutical company, announced today the publication of a research paper in the October 24, 2003 issue of Science entitled "A new class of bacterial RNA polymerase inhibitor affects nucleotide addition." The paper describes the identification and characterization of the novel "CBR703" class of inhibitors through combined efforts in biochemistry, genetics and structural modeling with contributions from both Cumbre researchers and scientists from the University of Wisconsin-Madison.

Co-author Robert Landick, Ph.D., a Professor of Bacteriology at the University of Wisconsin-Madison, whose laboratory is primarily focused on studies of regulatory mechanisms that control gene expression in bacteria, commented, "The Cumbre RNA polymerase inhibitors are a major breakthrough. They give us a powerful new tool to study the mechanism of the central enzyme in the process of gene expression. At least as importantly, they also hold great promise for the development of new antibiotics that target bacterial pathogens, which is now a high-priority need in both medicine and bio-defense."

A. Simon Lynch, Ph.D., Cumbre's Director of Research, added "We are excited about the development potential of the CBR703 series, and are pleased to be able to contribute to the RNA polymerase research community through provision of a novel experimental tool. We hope that ongoing efforts to determine high resolution X-ray structures of RNA polymerase-inhibitor complexes will both aid Cumbre's antibiotic development program and yield additional insight regarding the fundamental processes underlying the transcription elongation cycle."


'"/>

Contact: Robert England
bob.england@cumbre.biz
214-631-4700
Cumbre Inc.
23-Oct-2003


Page: 1

Related biology news :

1. International collaborators to form the Worldwide Protein Data Bank
2. From July 21-Aug. 20, Smith College and collaborators to retrace historic Harriman Expedition to Alaska
3. Wiley publishes Welcome to the Genome: A Users Guide to the Genetic Past, Present, and Future
4. Illustrated guidebook published for Chinese biomedical scientists and students
5. Warren Pharmaceuticals publishes results of preclinical evaluation
6. Articles on forest fire risks published in BioScience
7. Canine word-learning research published in Science
8. Articles on remote sensing in ecology published in BioScience
9. Professor publishes book on historic mosquito wars
10. McGill scientists publish detailed picture of how nutrients and other molecules get into cells
11. Revised guidelines published for testing for hereditary type of colorectal cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., ... the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New ... treatment of severe COVID-19. Approval of this IND allows Sentien to initiate a ...
(Date:8/21/2020)... ... August 19, 2020 , ... ... and expo uniting life science, data science, informatics and IT leaders goes VIRTUAL ... this period of uncertainty and change, Bio-IT takes the leadership role of keeping ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... in Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary ... Both Roche and J&J have annual Research and Development spending in excess of ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, ... its new tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes at ... requiring fast track capacity to provide patients with urgently needed vaccines and other ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, ... entered into a strategic partnership whereby Catalent will provide support for the development, ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... software for the life sciences industry, today announced the release of its ... specifically for Medical Science Liaisons (MSLs) and other field medical professionals. ...
Breaking Biology Technology:
Cached News: